Navigation Links
Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend
Date:11/1/2007

FERGUS FALLS, Minn., Nov. 1 /PRNewswire-FirstCall/ -- Otter Tail Corporation (Nasdaq: OTTR) announced financial results for the quarter ended September 30, 2007 with the following highlights:

-- Record third quarter revenues of $302.2 million.

-- Consolidated net income of $13.3 million for the third quarter of 2007

compared with $13.5 million for the third quarter of 2006.

-- Diluted earnings per share of $0.44 for the third quarter of 2007

compared with $0.45 for the third quarter of 2006.

Announcements:

-- On November 1, 2007 the Board of Directors declared a quarterly common

stock dividend of 29.25 cents per share, payable December 10. The Board

also declared quarterly dividends on the corporation's four series of

preferred stock, payable December 1. Dividends are payable to

shareholders of record as of November 15.

-- The corporation reaffirms its 2007 diluted earnings per share guidance

from continuing operations to be in the range of $1.60 to $1.80.

"Our third quarter financial results were in line with our expectations," said John Erickson, president and chief executive officer of Otter Tail Corporation. "Electric segment earnings were consistent with the same quarter a year ago, and increased profits from our manufacturing and food ingredient processing segments offset the anticipated reduction in earnings from our plastics segment. DMI Industries, our manufacturer of wind towers, produced excellent growth for the quarter. We reaffirm our 2007 earnings per share guidance to be within the range of $1.60 to $1.80."

For the nine months ended September 30, 2007 net income from continuing operations was
'/>"/>

SOURCE Otter Tail Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Cancer Patient Wins Lottery
2. UK’s Health Services Totterin
3. Virus Claims Harry Potter is Dead!
4. Potter and His Pals Light Up and Get Drunk Too!
5. Childline Gears Up for Distraught Potter Fans
6. Final Potter Book Already Out on the Web?
7. Harry Potter Final Book - Prediction and Expectations
8. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
9. PM announces a new health care order for India
10. Ramdoss Announces Introduction of RCH-II
11. Britain Announces Third Transfusion Related Mad Cow Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...sition in 2009 Continues Growth Trend , , NORTH...-- IPC The Hospitalist Company, Inc. (Nasdaq: IP...up practice company, announced today that it has a...Care Consultants, Inc. (MACC) in St. Louis, Missou... in the St. Louis market, where IPC has establishe...
(Date:1/8/2009)...n. 8 /PRNewswire-Asia/ -- Chindex International, I...a leading independent American,provider of Wester... Republic,of China, today announced that the Comp...ence, to be held in Shanghai on January 12th and 1...e will be held at the Pudong Shangri-,La hotel in...
(Date:1/8/2009)...8 A new educational Web...nce on drugs, biological products and medical devi...ality,s Centers for Education and Research on Ther... more than a dozen leading research centers nation...rmation Network ( CHAIN ) http://www.chainonline....
(Date:1/8/2009)...PRNewswire-FirstCall/ -- Cephalon, Inc . (Nasdaq:... Ph.D., Chairman and CEO will present at the J.P....ry 13, 2009 in San Francisco, CA at approximately ...presentation will be webcast live on the investor ..., The webcast will be archived for one week follow...
Breaking Medicine News(10 mins):Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...as accused the NHS of giving false information sin...r undergoing treatment// to remove a non-viable fe...told her that the fetus in her womb was dead. Afte...move the fetus on July 13, but after three weeks s...
...Department of Agriculture (USDA) has made availabl...trition Program// for Women, Infants and Children,... look at reducing the quantity of eggs, milk and j...proposal has indicated that the monthly quota for ...
...ion published a study in the August issue of their...t vegan diet is more effective in treating// type-...fect may be even better than single agent therapy ...n four disease markers; blood sugar control, chole...
...e journal, Cell Metabolism, researchers have descr...that are remarkably similar to those observed// in... aid in finding new therapies for the disease. ...ish becoming an important animal model to better u...
Other Medicine News:Health News:Proposal to revamp WIC food package 2Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 2Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 3Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 4
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire...e that predict a high likelihood of relapse in chi...hough the researchers caution that further researc...called IKZF1 or IKAROS, lead to leukemia relap...or future diagnostic tests to assess the risk of t...
(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua...puhua.com ), the worldwide leader in using stem ce...nnounced today six new globally experienced additi...cantly expand the hospital,s treatment capabilitie...tients. The six senior doctors include the disting...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In rece...omer, University of Memphis , scientists found th...Carn(R), is the first and only proven ingredient t...; thereby increasing blood nitrate/nitrate (NOx) i...sodilator and enables an increase in blood flow to...
(Date:1/6/2009)..., PARSIPPANY, N.J., Jan. 6 ...alty pharmaceutical company, announced today that ...e III SIMPLE trials to evaluate the,safety and ef...f EXPAREL(TM),(DepoBupivacaine) for prolonged pos...udies in hemorrhoidectomy and in total knee,arthr...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3NASA enhanced dust storm predictions to aid health community 5629 1NASA enhanced dust storm predictions to aid health community 5629 2NASA enhanced dust storm predictions to aid health community 5629 3Carmex Takes Moisture to the Next Level With New Carmex Moisture Plus 28TM 29 28007 1Notice of conference call and webcast 8677 1Notice of conference call and webcast 8677 2Cialis May Help Ease Pulmonary Hypertension 28000 1Cialis May Help Ease Pulmonary Hypertension 28000 2
...akthrough Will Aid in Developing Therapies to Prev...RYVILLE, Calif., May 10, 2007 /PRNewswire/ -- Kine...lopment company, announced,today the first method ...es in animals through the pathway known as reverse...n mechanism by which excess,cholesterol can be rem...
...POLIS, France, May 11, 2007 /PRNewswire-FirstCall/...pdate on the phase 2a,study for NCX 1000, which is... Pharma Inc. A preliminary analysis of 11 patient...tension confirmed,the safety profile of NCX 1000 b...pport the continuation of this clinical trial. As ...
Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3
The Cygnus-PFS Image-Guided Surgery System is the world's first portable and affordable image-guided surgery system.
Used to negotiate tortuous vessels.
Used for complex diagnostic and interventional procedures.
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package
Medicine Products: